Jill DeSimone is Director at Praxis Precision Medicines, Inc. (PRAX). They have made 1 open-market trade across 1 company since 2023, most recently 2026-06-24.
CIK 0001930479
1 open-market purchase totalling $25K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRAX | 2,337 | $566K |
Shares reported on the most recent Form 4, priced at the 2026-06-26 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.